Pretreatment of the cervix with 9-deoxy-16,16-dimethyl-9-methylene-prostaglandin E2 (Meteneprost) vaginal pessaries before first trimester legal abortion in nulliparae.
D000028:Abortion, Induced; D000029:Abortion, Legal; D001695:Biology; D001723:Birth Rate; D002584:Cervix Uteri; D003710:Demography; D004703:Endocrine System; D005193:Family Planning Services; D005298:Fertility; D005835:Genitalia; D005836:Genitalia, Female; D007747:Labor Stage, First; D010298:Parity; D010827:Physiology; D011153:Population; D011157:Population Dynamics; D011453:Prostaglandins; D013812:Therapeutics; D014566:Urogenital System; D014599:Uterus; D014619:Vacuum Curettage
D011453:Prostaglandins
Abortion, Induced; Abortion, Legal; Biology; Cervical Dilatation; Cervix; Demographic Factors; Endocrine System; Family Planning; Fertility; Fertility Control, Postconception; Fertility Measurements; Genitalia; Genitalia, Female; Nulliparity; Parity; Physiology; Population; Population Dynamics; Prostaglandins; Treatment; Urogenital System; Uterus; Vacuum Aspiration